Volume 54, Issue 6, Pages (June 2011)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Volume 65, Issue 1, Pages S82-S94 (October 2016)
Inflammasomes in liver diseases
Volume 61, Issue 4, Pages (October 2014)
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the ‘accordion’ regimen?  Patrick Marcellin, E. Jenny Heathcote,
Volume 59, Issue 6, Pages (December 2013)
Volume 68, Issue 5, Pages (May 2018)
Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou 
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Volume 51, Issue 6, Pages (December 2009)
The impact of hepatitis E in the liver transplant setting
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 42, Issue 1, Pages (January 2005)
NS5A inhibitors in the treatment of hepatitis C
Volume 65, Issue 1, Pages S82-S94 (October 2016)
Immigration and viral hepatitis
Virological tools to diagnose and monitor hepatitis C virus infection
Ype P. de Jong, Charles M. Rice, Alexander Ploss  Journal of Hepatology 
Living donor liver transplantation: is the hype over?
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Mesenchymal stromal cell therapy for liver diseases
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Yasuhiko Sugawara, Masatoshi Makuuchi 
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Volume 70, Issue 1, Pages (January 2019)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 61, Issue 1, Pages S69-S78 (November 2014)
‘Easy to treat’ genotypes were not created equal: Can rapid virological response (RVR) level the playing field?  Andres Duarte-Rojo, Elizabeth Jenny Heathcote,
Genomic risk of hepatitis C-related hepatocellular carcinoma
Darius Moradpour, Arash Grakoui, Michael P. Manns 
Autophagy in the liver Journal of Hepatology
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 58, Issue 4, Pages (April 2013)
Volume 61, Issue 1, Pages S45-S57 (November 2014)
Stephen Locarnini, Angelos Hatzakis, Ding-Shinn Chen, Anna Lok 
The changing role of beta-blocker therapy in patients with cirrhosis
EASL Clinical Practice Guidelines on hepatitis E virus infection
Volume 57, Issue 5, Pages (November 2012)
Volume 50, Issue 4, Pages (April 2009)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Immigration and viral hepatitis
HCV targeting of patients with cirrhosis
Pioglitazone as adjuvant therapy in chronic hepatitis C: Sequential rather than concomitant administration with pegylated interferon and ribavirin?  Lawrence.
Volume 63, Issue 1, Pages (July 2015)
Volume 51, Issue 2, Pages (August 2009)
Chronic hepatitis B in children and adolescents
Volume 60, Issue 6, Pages (June 2014)
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
U.P. Neumann, M. Biermer, D. Eurich, P. Neuhaus, T. Berg 
Volume 62, Issue 5, Pages (May 2015)
Reversion of disease manifestations after HCV eradication
Volume 60, Issue 6, Pages (June 2014)
Presentation transcript:

Volume 54, Issue 6, Pages 1250-1262 (June 2011) Management of hepatitis C virus genotype 4: Recommendations of An International Expert Panel  Mahmoud A. Khattab, Peter Ferenci, Stephanos J. Hadziyannis, Massimo Colombo, Michael P. Manns, Piero L. Almasio, Rafael Esteban, Ayman A. Abdo, Stephen A. Harrison, Nazir Ibrahim, Patrice Cacoub, Mohammed Eslam, Samuel S. Lee  Journal of Hepatology  Volume 54, Issue 6, Pages 1250-1262 (June 2011) DOI: 10.1016/j.jhep.2010.11.016 Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 1 A proposed algorithm for treating patients with chronic HCV-4 based on the kinetics of viral response (response-guided therapy). RVR, rapid viral response. Journal of Hepatology 2011 54, 1250-1262DOI: (10.1016/j.jhep.2010.11.016) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2011 54, 1250-1262DOI: (10. 1016/j. jhep. 2010 Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2011 54, 1250-1262DOI: (10. 1016/j. jhep. 2010 Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.